Normally, chasing rainbows is an inherently futile act. Masimo’s pursuit, however, is the rare one proven fruitful, with a new CE mark for its Rainbow SuperSensor. The single-use, adhesive SuperSensor ...
NEUCHATEL, Switzerland--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) announced today the CE marking and commercial launch in Europe of the single-patient-use adhesive rainbow ® SuperSensor™, compatible for ...
As Apple starts selling Apple Watch Series 9 and Ultra 2 models without the blood oxygen sensor enabled, Masimo CEO Joe Kiani confirmed to Bloomberg that there has been no chat with Apple about a ...
NEUCHATEL, Switzerland--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) announced today the CE marking of the rainbow ® Super DCI ®-mini sensor, a reusable spot-check sensor that features Masimo SET ® ...
Way back in 2013, Apple reportedly contacted medical tech company Masimo, as it was interested in forming a “working relationship” with the company. Following meetings in which details of Masimo’s ...
Masimo Corp. in Irvine received FDA clearance for the sale of its TFA-1 Single-Patient-Use Adhesive Forehead Sensor. The forehead sensor measures oxygen saturation, similar to the company’s current ...
(RTTNews) - Masimo (MASI) said that the U.S. FDA has cleared SedLine brain function monitoring for pediatric patients (1-17 years of age) and the SedLine Pediatric EEG Sensor. With this clearance, the ...
When a patient is receiving supplemental oxygen during surgery, there’s a risk that they’ll develop hyperoxia, where their arterial blood becomes oxygenated above normal levels, potentially leading to ...
Masimo Corporation MASI recently received the CE mark and commercially launched the single-patient-use adhesive rainbow SuperSensor in Europe. The SuperSensor is compatible for use with both Masimo ...
Masimo found out about restoration of pulse oximetry to the Apple Watch the same way that the rest of the world did, and is suing US Customs and Border Protection to stop the process. Apple has ...
A federal jury in California has ruled that Apple Inc. (NASDAQ: AAPL) must pay Masimo Corporation (NASDAQ: MASI) $634 million for infringing a patent related to blood-oxygen reading technology. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results